Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05704517Recruiting

Progressive Familial Intrahepatic Cholestasis in Indian Children - Establishing an Indian PFIC Registry

Role: collaborator

NCT06205043Not ApplicableRecruiting

Algorithm Guided DBS Programming in Parkinson's Patients

Role: lead

NCT01001637Not ApplicableTerminated

Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease

Role: lead

NCT00976430Not ApplicableTerminated

Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease

Role: lead

NCT02785653Phase 4Completed

Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium

Role: collaborator

All 5 trials loaded